15 publications

Name Date Type Actions

Monthly information regarding the total number of voting rights and shares making of the share capital - November 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

 		11/12/2013 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital - October 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

 		10/12/2013 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital - September 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

 		10/10/2013 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital - august 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

 		18/09/2013 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital - july 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

 		23/08/2013 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital - june 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

 		08/07/2013 Voting rights

Monthly information regarding the total number of voting rights and shares making of the share capital - mai 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

 		11/06/2013 Voting rights

Vétoquinol : 80 years striving for animal health worldwide

Founded in 1933, Vétoquinol is now a leading global animal health company.
The number 10 global animal health company and the third
largest in France, the Vétoquinol Group combines sustainability,
growth and independence in an increasingly competitive world
market.
Committed to the protection and well-being of both animals
and people, Vétoquinol creates, develops and sells veterinary
drugs and non-medical products all over the world.
The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats).
For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.

 		17/05/2013 Annual Report

Monthly information regarding the total number of voting rights and shares making of the share capital - april 2013

As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers »

 		11/05/2013 Voting rights

Financial statements 2012

1.1CONSOLIDATED FINANCIAL STATEMENTS p.4

 		30/04/2013 Annual Report